"It was a wonderful experience interacting with you and appreciate the way you have planned and executed the whole publication process within the agreed timelines.”
Subrat SaurabhAuthor of Kuch Woh Pal
Introduction to Crucial Pharmacology Trends, Volume 2:
Edited by Dr. Shiva Murthy N, Dr. Syed Shehnaz Ilyas, Dr. Melvin George, Dr. Phulen Sarma, and Dr. J. Thirunavukkarasu, this volume bridges foundational pharmacology and clinical application. With advancements like genomics and personalized therapies, clinical pharmacology is vital for optimizing patient care. This volume explores key topics in clinical research, animal studies, and recent innovations.
The clinical research section addresses critical issues, starting with biostatistical pitfalls and emphasizing precise methodologies. Chapters on evidence-based medicine, plagiarism prevention, and post-marketing surveillance highlight ethics and rigor. Topics on randomized controlled trials, technological advances, and research challenges reflect the evolving clinical research landscape.
The animal studies section highlights experimental models for drug evaluation, including antiglaucoma and type 2 diabetes models, and zebrafish in discovery. Simulated animal experiments and diuretic evaluations emphasize preclinical research's role.
The recent advances section explores innovations like AI in pharmacovigilance, nanopharmacology, and personalized medicine. Topics such as pharmacomicrobiomics, nasal drug delivery, monoclonal antibodies, vaccine development, and drug repositioning showcase cutting-edge advancements.
With these, this volume serves as a guide to navigating pharmacology’s dynamic evolution.
Dr Shiva Murthy N
The editorial team comprises five eminent pharmacologists, each a leader in their respective fields:
Dr. Shiva Murthy N, MBBS, MD (Gold Medalist), MBA, is a distinguished pharmacologist with over 23 years of expertise in clinical research, pharmacovigilance, academia, and healthcare innovation. A pioneer in his field, he has conducted more than 500 BA/BE studies and 20+ Phase I-IV trials, showcasing his mastery in medical writing, pharmacovigilance, and regulatory submissions.
Dr. Syed Ilyas Shehnaz is a seasoned clinical pharmacologist with nearly two decades of experience in medical research, teaching, and curriculum design. She holds an MD from Madras Medical College and a Ph.D. from Saveetha Institute of Medical and Technical Sciences. A FAIMER Fellow, she is a professor at Saveetha Medical College, Chennai, and has a rich academic history, including roles at JIPMER, India. With 54 publications, a patent, and a research grant, her contributions span diabetes research, pharmacology, and innovative pedagogy.
Dr. Melvin George, MBBS, MD, DM (Clinical Pharmacology), is a Professor and Head of the Centre for Clinical Pharmacology at SRM Medical College, Chennai, and Consultant at Hindu Mission Hospital. With 12+ years in clinical research and teaching, he has conducted numerous trials across therapeutic areas, published 105 research papers with an h-index of 22, and delivered over 110 guest lectures. He is a mentor and ethics committee member for various institutions.
Dr. Phulen Sarma, MBBS, MD, DM (Clinical Pharmacology), serves as an Assistant Professor at AIIMS Guwahati. He is an authority in systematic reviews, pharmacogenomics, and drug development, with over 110 PubMed-indexed articles and a global reputation as a top 2% scientist, as per Stanford-Elsevier rankings. He coordinates AIIMS Guwahati’s ADR and Medical Device Monitoring Centers and serves as Assistant Editor for the Indian Journal of Pharmacology.
Dr. J. Thirunavukkarasu, MD, is the Professor and Head of Pharmacology at Saveetha Medical College, Tamil Nadu. With 23 years in medical education, he is GCP-trained and an active member of several ethics committees. Known for his dedication to postgraduate training, he has guided countless students and authored numerous publications. Saveetha University has honored him with the "Best Teacher Award" seven times
Together, this accomplished editorial team combines decades of expertise to advance the field of pharmacology and clinical research.
